/PRNewswire/ Deciduous Therapeutics, an early stage immune therapy start-up, announced today the appointment of an independent board member, additional.
/PRNewswire/ Deciduous Therapeutics, an early stage immune therapy start-up, announced today the appointment of an independent board member, additional.
SAN FRANCISCO, Oct. 27, 2021 /PRNewswire/ Deciduous Therapeutics, an early stage immune therapy start-up, announced today the appointment of an independent board member, additional Scientific.